Olon Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is CLIDINIUM BROMIDE, with a corresponding US DMF Number 2809.
Remarkably, this DMF maintains an Active status since its submission on December 10, 1976, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 08, 2017, and payment made on April 13, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II